Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke (PLUS)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Merz Pharmaceuticals GmbH

ClinicalTrials.gov Identifier:

NCT01464307

First received: November 1, 2011

Last updated: July 31, 2015

Last verified: July 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2015
Primary Completion Date:	August 2014 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	July 31, 2015